Several: Manufacturer problems, higher demands, and ofcourse recalls.
Answered 4/24/2015
6.1k views
Many reasons: This is a complicated question that healthcare economists may need to answer. Some possible reasons include high cost for research and development, short patent life, generic availability, low reimbursement from insurers, over prescribing, hoarding of some medications by consumers, better treatment options, biotechnology, high fda requirements, etc.
Answered 7/8/2017
6.1k views
A doctor has provided 1 answer
A doctor has provided 1 answer
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question